Literature DB >> 23908360

Pediatric seizures.

Reet Sidhu1, Kohilavani Velayudam, Gregory Barnes.   

Abstract

On the basis of strong evidence, treatment is highly dependent on the seizure semiology results, electroencephalography (EEG) findings, and origin. • On the basis of moderate evidence and consensus, vigorous use of video EEG recordings and home video cameras should be used to delineate the epileptic syndromes. • On the basis of strong evidence, pediatric epilepsy syndromes have common comorbidities. As a consensus, some pediatric epilepsy centers consider referral to a neuropsychologist to be first-line care in these patients. • On the basis of strong evidence and consensus, antiepileptic drug therapy has its own complications and should be discontinued after an appropriate treatment course. • On the basis of moderate evidence and consensus, uncontrolled seizures put patients at risk for significant morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23908360     DOI: 10.1542/pir.34-8-333

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN: 0191-9601


  3 in total

1.  Exploring Variances of White Matter Integrity and the Glymphatic System in Simple Febrile Seizures and Epilepsy.

Authors:  Mustafa Salimeen Abdelkareem Salimeen; Congcong Liu; Xianjun Li; Miaomiao Wang; Martha Singh; Shuqing Si; Mengxuan Li; Yannan Cheng; Xiaoyu Wang; Huifang Zhao; Fan Wu; Yuli Zhang; Habib Tafawa; Anuja Pradhan; Guanyu Yang; Jian Yang
Journal:  Front Neurol       Date:  2021-04-21       Impact factor: 4.003

2.  Impact of exclusive breast feeding until six months of age on common illnesses: A prospective observational study.

Authors:  Asha J Penugonda; Roshni J Rajan; Arul P Lionel; Rajeev Z Kompithra; Lakshmanan Jeyaseelan; Leni G Mathew
Journal:  J Family Med Prim Care       Date:  2022-03-18

Review 3.  Benign and severe early-life seizures: a round in the first year of life.

Authors:  Piero Pavone; Giovanni Corsello; Martino Ruggieri; Silvia Marino; Simona Marino; Raffaele Falsaperla
Journal:  Ital J Pediatr       Date:  2018-05-15       Impact factor: 2.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.